Greater Combined Reductions In HbA1c ≥1.0% And Weight ≥5.0% With Semaglutide Versus Comparators In Type 2 Diabetes

Helena W Rodbard, Srikanth Bellary, Irene Hramiak, Yutaka Seino, Robert Silver, Lars Holm Damgaard, Gurudutt Nayak, Jeppe Zacho, Vanita R Aroda

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Greater Combined Reductions In HbA1c ≥1.0% And Weight ≥5.0% With Semaglutide Versus Comparators In Type 2 Diabetes'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science